MedPath

Engelhard Arzneimittel GmbH & Co. KG

🇩🇪Germany
Ownership
Private
Established
1872-01-01
Employees
1
Market Cap
-
Website
http://www.engelhard.de

Clinical Trials

14

Active:9
Completed:4

Trial Phases

4 Phases

Phase 1:4
Phase 2:2
Phase 3:1
+1 more phases

Drug Approvals

7

CIMA_AEMPS:5
PHILIPPINES:2

Drug Approvals

PROSPANTUS JARABE EN SOBRES

Approval Date
Jul 14, 2025
CIMA_AEMPS

ERAZABAN 100 MG/G CREMA

Approval Date
Jul 14, 2025
CIMA_AEMPS

ABRILAR JARABE

Approval Date
Jul 14, 2025
CIMA_AEMPS

PROSPANTUS JARABE

Approval Date
Jul 14, 2025
CIMA_AEMPS

PROSPANTUS PASTILLAS DE GOMA

Approval Date
Jul 14, 2025
CIMA_AEMPS

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 1
4 (50.0%)
Phase 2
2 (25.0%)
Not Applicable
1 (12.5%)
Phase 3
1 (12.5%)

Sinolpan® Pharmacy Non-interventional Study - Quality of Live

Completed
Conditions
Bronchitis
Rhinosinusitis Acute
Rhinosinusitis Chronic
Interventions
Drug: Nasal Decongestant
First Posted Date
2021-01-11
Last Posted Date
2022-10-12
Lead Sponsor
Engelhard Arzneimittel GmbH & Co.KG
Target Recruit Count
350
Registration Number
NCT04703673
Locations
🇩🇪

ClinCompetence Cologne GmbH, Köln, Germany

RCT to Evaluate the Efficacy and Safety of Ivy Leaves Cough Liquid vs. Placebo in the Treatment of Acute Cough

Phase 2
Completed
Conditions
Acute Cough
Interventions
Drug: Ivy Leaves Cough Liquid
Drug: Placebo
First Posted Date
2015-03-24
Last Posted Date
2015-09-03
Lead Sponsor
Engelhard Arzneimittel GmbH & Co.KG
Target Recruit Count
181
Registration Number
NCT02396706
Locations
🇩🇪

Medizentrum Essen-Borbeck, Essen, Germany

Tyrosur® Gel-Investigation on Wound Healing Efficacy

Phase 2
Completed
Conditions
Wounds
Wound Healing
Interventions
Drug: Drug containing the active ingredient
Drug: Placebo
First Posted Date
2010-10-25
Last Posted Date
2010-10-26
Lead Sponsor
Engelhard Arzneimittel GmbH & Co.KG
Target Recruit Count
33
Registration Number
NCT01227759

Prospan® Hustenzäpfchen - Investigation on Efficacy and Tolerability in Children

Phase 3
Conditions
Symptoms of Acute Bronchitis Accompanied by Coughing
Interventions
Drug: Suppositories containing Ivy leaves dry extract
Drug: Placebo
First Posted Date
2010-05-20
Last Posted Date
2011-06-15
Lead Sponsor
Engelhard Arzneimittel GmbH & Co.KG
Target Recruit Count
1400
Registration Number
NCT01127048
Locations
🇩🇪

Engelhard Arzneimittel GmbH & Co. KG, Niederdorfelden, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.